ホーム › びまん性大細胞型B細胞リンパ腫 › ミズーリ州
ミズーリ州におけるびまん性大細胞型B細胞リンパ腫の臨床試験
ミズーリ州内の拠点で、びまん性大細胞型B細胞リンパ腫に関する8件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06649812A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166), Bridgeton
- Truman Medical Center ( Site 0122), Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06717347Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Children's Mercy Hospital ( Site 1024), Kansas City
被験者募集中第1/2相
6 Months – 25 Years · 全性別 · 2026/09/17更新 · NCT06395103Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- University of Missouri - Ellis Fischel Cancer Center, Columbia
- MidAmerica Cancer Care, Kansas City
- Washington University School of Medicine - Siteman Cancer Center, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/31更新 · NCT06500273CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
- Washington University School of Medicine, St Louis
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/08/28更新 · NCT06687772DALY II USA/ MB-CART2019.1 for DLBCL
- Washington University, St. Louis, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/13更新 · NCT04792489Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2025/10/20更新 · NCT05890352Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
- Siteman Cancer Center at Washington University, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2024/09/26更新 · NCT06238648ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。